Trial intelligence / Profile preview

Paricalcitol for reduction of proteinuria in kidney transplant recipients

2011-006120-20Phase 3Completed

Sponsor
University Medical Centre Ljubljana
Start
Jan 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in proteinuria and Kidney allograft status (RTx) comparing Paricalcitol with Placebo (2 arms). Started Jan 2012; status: completed.

02

Drugs

paricalcitol
03

Conditions

proteinuriaKidney allograft status (RTx)

Beyond the preview

Go deeper on 2011-006120-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-006120-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call